Diakine Therapeutics Inc is categorized under Commercial Biotechnical Research in Norfolk, VA and active since 2012.
Diakine Therapeutics Inc was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Keith Ignotz at the company’s single location by writing to 338 Raleigh Avenue, Norfolk, Virginia VA 23507 or by phoning (757) 227-3426. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Diakine Therapeutics Inc |
| Contact Person: | Keith Ignotz |
| Address: | 338 Raleigh Avenue, Norfolk, Virginia 23507 |
| Phone Number: | (757) 227-3426 |
| Website Address: | isletsciences.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Diakine Therapeutics Inc was started in 2012 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Keith Ignotz for inquiries that concern Diakine Therapeutics Inc by calling the company number (757) 227-3426, as your correspondence is most welcome. Additionally, the physical location of the single location of Diakine Therapeutics Inc can be found at the coordinates 36.859387,-76.293241 as well as the street address 338 Raleigh Avenue in Norfolk, Virginia 23507.
For its online presence, you may visit Diakine Therapeutics Inc’s website at isletsciences.com and engage with its social media outlets through on Twitter and on Facebook.